Letermovir Impurity 17 | CAS 215649-80-2 - Request Quote
Letermovir Impurity 17
| SZ CAT No: | SZ-L052026 |
| CAS No | 215649-80-2 |
| Mol.F. | C11H14N2O2 |
| Mol.Wt. | 206.2 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 1268990-40-4 (HCl salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Letermovir Impurity 17 is chemically 1-(3-Methoxyphenyl)piperazin-2-one. Letermovir Impurity 17 is supplied with detailed characterization data compliant with regulatory guideline. Letermovir Impurity 17 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Letermovir.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 215649-80-2
Purchase 215649-80-2
Order 215649-80-2
Enquire 215649-80-2
price of 215649-80-2
215649-80-2 Supplier
215649-80-2 Manufacturer
215649-80-2 Exporter
buy high quality Letermovir Impurity 17
Purchase Letermovir Impurity 17
Letermovir Impurity 17 suppliers
Letermovir Impurity 17 manufacturers
Letermovir Impurity 17 price
Order Letermovir Impurity 17
Enquire Letermovir Impurity 17
Letermovir Impurity 17 cost
Letermovir Impurity 17 Supplier
Letermovir Impurity 17 Distributor
Letermovir Impurity 17 for Method Validation
Letermovir Reference Standard
Letermovir Impurity 17 for ANDA Filing
Letermovir Impurity 17 for Forced Degradation Studies
Letermovir Impurity 17 Identification Standards
Letermovir Impurity 17 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.